{"id":"cbd","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Fatigue"},{"rate":"5-15","effect":"Diarrhea"},{"rate":"5-10","effect":"Appetite changes"},{"rate":"5-10","effect":"Elevated liver enzymes"},{"rate":"5-15","effect":"Somnolence"}]},"_chembl":null,"_dailymed":{"setId":"4c493c0b-c58e-cb56-e063-6394a90a9395","title":"JUST CBD - PAIN RELIEF (MENTHOL, CAMPHOR) GEL [JUST BRANDS LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CBD is a non-intoxicating cannabinoid that does not directly bind CB1 or CB2 receptors with high affinity but instead acts as an allosteric modulator and interacts with multiple receptor systems. It enhances endocannabinoid tone, modulates serotonergic and vanilloid signaling, and reduces neuroinflammation, contributing to its therapeutic effects across multiple conditions.","oneSentence":"CBD (cannabidiol) modulates endocannabinoid signaling and interacts with multiple receptors including serotonin 5-HT1A, TRPV1, and GPR55 to produce anti-inflammatory, anxiolytic, and analgesic effects.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:29:15.945Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Epilepsy (Dravet syndrome, Lennox-Gastaut syndrome)"},{"name":"Chronic pain"},{"name":"Anxiety disorders"},{"name":"Inflammation-related conditions"}]},"trialDetails":[{"nctId":"NCT07498023","phase":"PHASE1, PHASE2","title":"EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2025-09-15","conditions":"Fibromyalgia","enrollment":36},{"nctId":"NCT02548559","phase":"PHASE2","title":"Sublingual Cannabidiol for Anxiety","status":"COMPLETED","sponsor":"Staci Gruber, Ph.D.","startDate":"2018-08-14","conditions":"Anxiety","enrollment":46},{"nctId":"NCT05942911","phase":"PHASE2","title":"Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis","status":"TERMINATED","sponsor":"Incannex Healthcare Ltd","startDate":"2023-11-22","conditions":"Rheumatoid Arthritis","enrollment":20},{"nctId":"NCT03653156","phase":"","title":"China Cognition and Aging Study","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2000-01-01","conditions":"Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD)","enrollment":100000},{"nctId":"NCT05020106","phase":"","title":"The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2018-09-01","conditions":"Alzheimer's Disease","enrollment":3200},{"nctId":"NCT04850053","phase":"","title":"Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2020-08-26","conditions":"Alzheimer's Disease","enrollment":1500},{"nctId":"NCT06069713","phase":"NA","title":"Consumer Perceptions of Cannabidiol (CBD) Health Claims","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2023-10-09","conditions":"Perceptions","enrollment":3504},{"nctId":"NCT05037487","phase":"PHASE1","title":"Evaluation of Smoked THC and CBD in Men and Women","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-09-01","conditions":"Drug Abuse, Intoxication by Drug, Impairment","enrollment":19},{"nctId":"NCT06512389","phase":"PHASE2","title":"Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-08-16","conditions":"Alcohol Use Disorder","enrollment":36},{"nctId":"NCT03307382","phase":"NA","title":"Single-operator Digital Cholangioscopy for the Diagnosis of Malignant and Benign Biliary Strictures","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2015-12-15","conditions":"Biliary Stricture","enrollment":40},{"nctId":"NCT06283862","phase":"NA","title":"MIVetsCan: Can-Coach Trial (Phase 2)","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2024-04-04","conditions":"Chronic Pain","enrollment":468},{"nctId":"NCT06381791","phase":"PHASE1, PHASE2","title":"CBD for Pain Following Orthopedic Shoulder Surgery","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2024-05-24","conditions":"Shoulder Osteoarthritis, Rotator Cuff Injuries","enrollment":80},{"nctId":"NCT06148038","phase":"PHASE1","title":"CBD for Breast Cancer Primary Tumors","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-06-15","conditions":"Breast Cancer","enrollment":60},{"nctId":"NCT06113237","phase":"","title":"Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy","status":"RECRUITING","sponsor":"Jazz Pharmaceuticals","startDate":"2025-08-05","conditions":"Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse","enrollment":50},{"nctId":"NCT05909267","phase":"NA","title":"Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2023-07-26","conditions":"Depressive Disorder, Major","enrollment":165},{"nctId":"NCT06924827","phase":"PHASE4","title":"A Study to Investigate the Transition of Children From 'Artisanal\" Cannabidiol (CBD) to Epidiolex","status":"NOT_YET_RECRUITING","sponsor":"Elizabeth Donner","startDate":"2026-06-01","conditions":"Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)","enrollment":25},{"nctId":"NCT05044819","phase":"PHASE4","title":"Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jazz Pharmaceuticals","startDate":"2021-07-07","conditions":"Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex","enrollment":154},{"nctId":"NCT04587791","phase":"EARLY_PHASE1","title":"Cannabidiol in Opioid Use Disorder and Chronic Pain","status":"RECRUITING","sponsor":"Yale University","startDate":"2021-12-08","conditions":"Chronic Pain, Opioid Use Disorder","enrollment":34},{"nctId":"NCT04246437","phase":"PHASE1","title":"[18F]F-DOPA Imaging in Patients With Autonomic Failure","status":"RECRUITING","sponsor":"Daniel Claassen","startDate":"2020-02-04","conditions":"Autonomic Failure, Pure Autonomic Failure, Parkinson Disease","enrollment":40},{"nctId":"NCT05427630","phase":"PHASE2","title":"Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment","status":"SUSPENDED","sponsor":"University of California, San Diego","startDate":"2023-02-15","conditions":"Migraine, Cannabis, THC","enrollment":20},{"nctId":"NCT05753007","phase":"PHASE2","title":"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients","status":"TERMINATED","sponsor":"Mclean Hospital","startDate":"2024-02-15","conditions":"Glioblastoma","enrollment":2},{"nctId":"NCT05781711","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-06","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT06708299","phase":"PHASE3","title":"CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)","status":"RECRUITING","sponsor":"Cardiol Therapeutics Inc.","startDate":"2025-04-07","conditions":"Recurrent Pericarditis","enrollment":110},{"nctId":"NCT06113640","phase":"PHASE2, PHASE3","title":"Montelukast in Parkinson Disease","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2023-11-05","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT04577833","phase":"PHASE1","title":"A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2020-11-13","conditions":"Prostatic Neoplasms","enrollment":136},{"nctId":"NCT07471347","phase":"NA","title":"Exploring The Effect Of Cannabidiol On Cannabis Tolerance Using A Novel Vaporiser Device In Heavy Users (Stage 1)","status":"NOT_YET_RECRUITING","sponsor":"King's College London","startDate":"2026-03","conditions":"Cannabis Intoxication","enrollment":10},{"nctId":"NCT06533657","phase":"PHASE2","title":"Unique Treatment of Oncology Pain in Advanced Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ZYUS Life Sciences Inc.","startDate":"2025-06-12","conditions":"Cancer Pain","enrollment":20},{"nctId":"NCT07016971","phase":"PHASE1","title":"CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-04-01","conditions":"Chemotherapy-Induced Peripheral Neuropathy","enrollment":12},{"nctId":"NCT07151378","phase":"PHASE3","title":"Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2025-10-27","conditions":"PARKINSON DISEASE (Disorder)","enrollment":150},{"nctId":"NCT05864846","phase":"PHASE4","title":"A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jazz Pharmaceuticals","startDate":"2023-06-29","conditions":"Tuberous Sclerosis Complex Associated Neuropsychiatric Disease","enrollment":79},{"nctId":"NCT07233239","phase":"PHASE1","title":"A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures","status":"RECRUITING","sponsor":"Jazz Pharmaceuticals","startDate":"2025-11-26","conditions":"Focal Seizures","enrollment":100},{"nctId":"NCT07459920","phase":"PHASE2","title":"Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2026-04-01","conditions":"Advanced Malignant Solid Tumor","enrollment":156},{"nctId":"NCT04495725","phase":"NA","title":"Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain","status":"COMPLETED","sponsor":"Vireo Health","startDate":"2020-10-06","conditions":"Opioid Use, Marijuana, Chronic Pain","enrollment":270},{"nctId":"NCT07462559","phase":"PHASE1","title":"KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-03-04","conditions":"Drug Drug Interaction","enrollment":12},{"nctId":"NCT07393672","phase":"PHASE2","title":"Effects of Hemp-Derived Cannabinoids on Menopause Symptoms","status":"RECRUITING","sponsor":"Washington State University","startDate":"2026-02-11","conditions":"Menopause, Perimenopause","enrollment":104},{"nctId":"NCT07123467","phase":"PHASE3","title":"Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder","status":"RECRUITING","sponsor":"Wayne State University","startDate":"2025-11-03","conditions":"Generalized Anxiety Disorder (GAD), Anxiety Disorders","enrollment":90},{"nctId":"NCT05149898","phase":"PHASE2","title":"Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)","status":"COMPLETED","sponsor":"Harmony Biosciences Management, Inc.","startDate":"2020-02-19","conditions":"22Q11.2 Deletion Syndrome","enrollment":20},{"nctId":"NCT05961501","phase":"PHASE2, PHASE3","title":"The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin","status":"ENROLLING_BY_INVITATION","sponsor":"Wroclaw Medical University","startDate":"2025-04-01","conditions":"Myalgia, Muscle Pain, Orofacial Pain","enrollment":42},{"nctId":"NCT06405646","phase":"","title":"Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin","status":"ENROLLING_BY_INVITATION","sponsor":"Wroclaw Medical University","startDate":"2025-04-01","conditions":"Myalgia, Muscle Pain, Orofacial Pain","enrollment":102},{"nctId":"NCT05651607","phase":"PHASE2","title":"Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-09-07","conditions":"Hereditary Epidermolysis Bullosa","enrollment":10},{"nctId":"NCT04875286","phase":"","title":"Patient Reported Symptom Control With THC or CBD Use","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-03","conditions":"Cancer-Associated Pain, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":200},{"nctId":"NCT06129591","phase":"PHASE1","title":"Topical CBD Scar Healing Study","status":"NOT_YET_RECRUITING","sponsor":"University of Oklahoma","startDate":"2026-05","conditions":"Paramedian Forehead Flap","enrollment":22},{"nctId":"NCT03431363","phase":"","title":"Medical Cannabis During Chemoradiation for Head and Neck Cancer","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-05-18","conditions":"Head and Neck Cancer","enrollment":30},{"nctId":"NCT06840899","phase":"PHASE2","title":"CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-02-13","conditions":"Supra-sacral Spinal Cord Injury, Spinal Cord Injury, Urinary Incontinence","enrollment":20},{"nctId":"NCT06800066","phase":"NA","title":"RCT-Consumer Perceptions of Cannabidiol (CBD) Health Claims","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2025-01-08","conditions":"Prevention","enrollment":460},{"nctId":"NCT07445568","phase":"NA","title":"Home-Based Quadriceps Isometric Exercise for Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"Universidad del Valle de México, Campus Cuernavaca","startDate":"2025-09-01","conditions":"Older Adults (60 - 85 Years Old), OA Knee","enrollment":50},{"nctId":"NCT07444892","phase":"PHASE2","title":"Levodopa for Diabetic Retinopathy","status":"COMPLETED","sponsor":"Emory University","startDate":"2022-04-18","conditions":"Diabetic Retinopathy","enrollment":230},{"nctId":"NCT05261321","phase":"PHASE1","title":"Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2022-10-15","conditions":"Healthy","enrollment":20},{"nctId":"NCT07442591","phase":"PHASE1","title":"A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants","status":"NOT_YET_RECRUITING","sponsor":"Shanghai WD Pharmaceutical Co., Ltd.","startDate":"2026-03","conditions":"Healhty","enrollment":12},{"nctId":"NCT07434973","phase":"PHASE3","title":"Stratification and Treatment in Early Psychosis Study - PROMOTE","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2026-05-01","conditions":"Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, Clinical High Risk for Developing Psychosis","enrollment":586},{"nctId":"NCT06333041","phase":"PHASE2, PHASE3","title":"Study of Cannabidiol in Sanfilippo Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2026-03-15","conditions":"Sanfilippo Syndrome, Mucopolysaccharidosis III","enrollment":35},{"nctId":"NCT05067387","phase":"PHASE1","title":"Evaluation of Oral THC and CBD in Men and Women","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-04-15","conditions":"Drug Abuse, Intoxication by Drug, Impairment","enrollment":22},{"nctId":"NCT07434895","phase":"EARLY_PHASE1","title":"Repeated CBD Administration and Cannabis Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Hannah Harris","startDate":"2026-03","conditions":"Cannabis, Abuse Liability, Experimental Pain in Healthy Human Participants","enrollment":23},{"nctId":"NCT05351801","phase":"PHASE2","title":"Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-06-21","conditions":"Neuropathic Pain, Peripheral Neuropathic Pain","enrollment":320},{"nctId":"NCT01800214","phase":"","title":"The Sunnybrook Dementia Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"1995-09","conditions":"Dementia","enrollment":1800},{"nctId":"NCT06234631","phase":"PHASE2","title":"Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Chad Brummett","startDate":"2024-03-13","conditions":"Knee Replacement Surgery, Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT05485831","phase":"","title":"Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY","status":"RECRUITING","sponsor":"Jazz Pharmaceuticals","startDate":"2025-02-24","conditions":"Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex","enrollment":100},{"nctId":"NCT04550377","phase":"PHASE2","title":"Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2021-05-26","conditions":"Post Traumatic Stress Disorder, Traumatic Brain Injury","enrollment":120},{"nctId":"NCT07279558","phase":"PHASE2","title":"Cannabidiol and Alcohol Use Disorder Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02-01","conditions":"Alcohol Use Disorder","enrollment":180},{"nctId":"NCT05490511","phase":"PHASE1","title":"Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus","status":"COMPLETED","sponsor":"Indiana University","startDate":"2022-10-31","conditions":"CBD, Transplant Complication, Kidney Disease, Chronic","enrollment":57},{"nctId":"NCT04978428","phase":"PHASE2","title":"Epidiolex in Obsessive Compulsive Disorder and Related Disorders","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2022-04-14","conditions":"Obsessive-Compulsive Disorder, Trichotillomania (Hair-Pulling Disorder), Tourette Syndrome","enrollment":4},{"nctId":"NCT03529448","phase":"PHASE1, PHASE2","title":"TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma","status":"COMPLETED","sponsor":"Grupo Español de Investigación en Neurooncología","startDate":"2023-08-18","conditions":"Glioblastoma","enrollment":33},{"nctId":"NCT07148206","phase":"PHASE3","title":"Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial","status":"NOT_YET_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-05","conditions":"Opioid Use Disorder","enrollment":40},{"nctId":"NCT07207486","phase":"","title":"In-depth Analysis of Cholesterol Metabolism and Related Biomarkers in the Pathogenesis and Progression of the Disease in Neurodegenerative Dementias","status":"RECRUITING","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2023-06-05","conditions":"Dementias, Neurodegenerative Dementia","enrollment":80},{"nctId":"NCT06930872","phase":"PHASE1","title":"Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates","status":"COMPLETED","sponsor":"Harmony Biosciences Management, Inc.","startDate":"2025-06-06","conditions":"Drug Interaction","enrollment":29},{"nctId":"NCT05066308","phase":"PHASE2","title":"Cannabidiol for Reduction of Brain Neuroinflammation","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-01-04","conditions":"Back Pain, Depressive Symptoms","enrollment":80},{"nctId":"NCT04469959","phase":"PHASE2","title":"Dopaminergic Dysfunction in Late-Life Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-02-15","conditions":"Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant","enrollment":100},{"nctId":"NCT07389915","phase":"","title":"A Convolutional Neural Network for Difficult Biliary Cannulation","status":"NOT_YET_RECRUITING","sponsor":"University of La Laguna","startDate":"2026-02-01","conditions":"Difficult Biliary Cannulation","enrollment":600},{"nctId":"NCT06854783","phase":"PHASE1","title":"Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers","status":"COMPLETED","sponsor":"Tiamat Australia Pty Ltd","startDate":"2025-07-14","conditions":"Pharmacokinetics","enrollment":20},{"nctId":"NCT06222268","phase":"PHASE1","title":"Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery","status":"NOT_YET_RECRUITING","sponsor":"Wayne State University","startDate":"2026-03","conditions":"PTSD, Post Traumatic Stress Disorder","enrollment":280},{"nctId":"NCT02926859","phase":"PHASE2","title":"Enhancing Recovery in Early Schizophrenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2017-04-08","conditions":"Schizophrenia","enrollment":180},{"nctId":"NCT06845124","phase":"PHASE2","title":"A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence","status":"RECRUITING","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2025-07-22","conditions":"Alcohol Addiction, Alcoholism","enrollment":150},{"nctId":"NCT07186283","phase":"PHASE1","title":"Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers","status":"COMPLETED","sponsor":"NW PharmaTech Ltd","startDate":"2025-09-22","conditions":"PK in Healthy Volunteers","enrollment":14},{"nctId":"NCT06589258","phase":"NA","title":"Cannabidiol Into Breastmilk","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-10-06","conditions":"Breast Feeding","enrollment":60},{"nctId":"NCT06014424","phase":"PHASE2","title":"Cannabidiol Medication Intervention Trial","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-09-27","conditions":"Alzheimer Disease","enrollment":40},{"nctId":"NCT06831500","phase":"PHASE1, PHASE2","title":"Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.","status":"RECRUITING","sponsor":"Julien Bally","startDate":"2025-07-18","conditions":"Multi-system Atrophy - Parkinsonian Type, Orthostatic Hypotension, Dysautonomic, Parkinson Disease","enrollment":36},{"nctId":"NCT07240818","phase":"NA","title":"Comparison of FNB to EUS-CNB for Pancreatic Lesions","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-03-01","conditions":"Diagnosis of a Pancreaticobiliary Disorder, Biopsy, EUS Guided Biopsy","enrollment":30},{"nctId":"NCT06075771","phase":"PHASE4","title":"Dopaminergic Therapy for Anhedonia - 2","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-11-21","conditions":"Anhedonia, Depression","enrollment":70},{"nctId":"NCT04105231","phase":"PHASE2","title":"Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lone Baandrup","startDate":"2021-06-01","conditions":"Dual Diagnosis","enrollment":64},{"nctId":"NCT07370532","phase":"PHASE2","title":"Etoricoxib in Patients With Parkinsonian Disease","status":"NOT_YET_RECRUITING","sponsor":"Ihab Elsayed Hassan","startDate":"2026-06-30","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT05832281","phase":"PHASE2","title":"Role of CBD in Improving Alexithymia","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2023-11-28","conditions":"Alexithymia, HIV","enrollment":5},{"nctId":"NCT07271030","phase":"NA","title":"The Use of Cannabidiol Suppositories for Sexual Pain","status":"RECRUITING","sponsor":"London Metropolitan University","startDate":"2026-01-16","conditions":"Well-Being, Psychological, Quality of Life, Sexual Behavior","enrollment":50},{"nctId":"NCT05052541","phase":"PHASE3","title":"Safety and Efficacy of Oral Cannabis in Chronic Spine Pain","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-01","conditions":"Back Pain, Neck Pain","enrollment":157},{"nctId":"NCT07362407","phase":"","title":"Analysis of the Therapeutic and Clinical Profile of Cannabinoid Treatments: A Real-World Study","status":"NOT_YET_RECRUITING","sponsor":"Santa Catarina Federal University","startDate":"2026-02","conditions":"Chronic Pain, Depression Disorders, Anxiety Disorders","enrollment":384},{"nctId":"NCT06878417","phase":"NA","title":"Cannabinoids for Osteoarthritis Pain Effectiveness Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-01-15","conditions":"Osteoarthritis of Knee, Osteoarthritis Hip","enrollment":100},{"nctId":"NCT02556008","phase":"","title":"Cannabidiol for Pediatric Epilepsy (Compassionate Use)","status":"NO_LONGER_AVAILABLE","sponsor":"University of California, Los Angeles","startDate":"","conditions":"Refractory Childhood Epilepsy","enrollment":""},{"nctId":"NCT05041647","phase":"PHASE2","title":"Cannabinoids as a Treatment for Insomnia in Major Depression","status":"COMPLETED","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2023-08-28","conditions":"Insomnia, Depressive Disorder, Major, Sleep Disorder","enrollment":14},{"nctId":"NCT07359976","phase":"NA","title":"Pharmacokinetic Evaluation of a Natural CBD Extract","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-01-04","conditions":"Pharmacokinetics of CBD Extract, Oral and Topical Administrations","enrollment":20},{"nctId":"NCT07313176","phase":"","title":"Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease","status":"RECRUITING","sponsor":"Britannia Pharmaceuticals Ltd.","startDate":"2026-01","conditions":"Advanced Parkinson Disease","enrollment":215},{"nctId":"NCT05043103","phase":"","title":"Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Britannia Pharmaceuticals Ltd.","startDate":"2021-07-06","conditions":"Advanced Parkinson Disease","enrollment":312},{"nctId":"NCT06785298","phase":"PHASE2, PHASE3","title":"Fexofenadine as Adjuvant Therapy in Parkinson Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-12-10","conditions":"Parkinson Disease","enrollment":46},{"nctId":"NCT05388058","phase":"PHASE2","title":"Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-06-09","conditions":"Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm","enrollment":40},{"nctId":"NCT07298408","phase":"PHASE1, PHASE2","title":"Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Florida A&M University","startDate":"2026-01-02","conditions":"Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies","enrollment":20},{"nctId":"NCT06261489","phase":"PHASE2","title":"Cannabis (THC vs. CBD) in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Calgary","startDate":"2025-12-05","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT05351905","phase":"NA","title":"Improving Pain Disability With the Use of Oral Cannabinoids","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2022-11-22","conditions":"Chronic Pain, Opioid Use, Cannabis","enrollment":51},{"nctId":"NCT06647641","phase":"","title":"The CurePSP Genetics Program","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-08","conditions":"PSP, PSP - Progressive Supranuclear Palsy, Corticobasal Syndrome","enrollment":1000},{"nctId":"NCT06544291","phase":"PHASE2","title":"Combined THC and CBD for OUD and Chronic Pain","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-10-22","conditions":"Chronic Pain, Opioid Use Disorder","enrollment":147},{"nctId":"NCT07336576","phase":"","title":"Treatment Strategy for Adult Congenital Biliary Dilation","status":"COMPLETED","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2024-10-01","conditions":"Congenital Biliary Dilation","enrollment":234},{"nctId":"NCT07148843","phase":"PHASE2, PHASE3","title":"Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-04-01","conditions":"Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification, Craving","enrollment":105},{"nctId":"NCT07329803","phase":"NA","title":"Pre-cut Versus Intentional Double Guidewire for ERCP Cannulation: Prospective, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2026-01-25","conditions":"ERCP, Choledocholithiasis, Biliary Drainage","enrollment":840}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13557,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cannabidiol","No brand names as cannabidiol is not commercially available","AVCN319301a","CBD tincture","CBD cream"],"phase":"marketed","status":"active","brandName":"CBD","genericName":"CBD","companyName":"Stero Biotechs Ltd.","companyId":"stero-biotechs-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CBD (cannabidiol) modulates endocannabinoid signaling and interacts with multiple receptors including serotonin 5-HT1A, TRPV1, and GPR55 to produce anti-inflammatory, anxiolytic, and analgesic effects. Used for Epilepsy (Dravet syndrome, Lennox-Gastaut syndrome), Chronic pain, Anxiety disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}